# Healing of Ischemic Leg Ulcers in Patients Treated With iSONIAzid

> **NCT04802928** · PHASE2 · WITHDRAWN · sponsor: **Pharma 2100**

## Conditions studied

- Arterial Leg Ulcer

## Interventions

- **DRUG:** Isoniazid 300 milligram
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04802928
- **Lead sponsor:** Pharma 2100
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-04
- **Primary completion:** 2008-09
- **Final completion:** 2008-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Patients fulfilling the criteria could not be found.
- **Last updated:** 2021-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04802928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04802928, "Healing of Ischemic Leg Ulcers in Patients Treated With iSONIAzid". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04802928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*